Cardio Connections: Atherosclerosis and CVD
Elevate your essential knowledge and skills related to cardiovascular nursing this May by joining national thought leaders at PCNA’s Cardio Connections virtual summit.
Join us for an engaging virtual summit designed specifically for cardiovascular nurses, focusing on the latest evidence-based strategies in managing atherosclerotic cardiovascular disease (ASCVD), peripheral arterial disease (PAD), and obstructive sleep apnea (OSA). This summit will feature expert-led sessions exploring pathophysiology, risk stratification, and interdisciplinary care approaches to optimize patient outcomes. Attendees will gain practical tools for clinical decision-making, patient education, and long-term disease management. Whether you’re in acute care, outpatient settings, or cardiac rehabilitation, this summit offers valuable insights to enhance your practice and improve cardiovascular health across diverse patient populations. Don’t miss this opportunity to advance your expertise!
Agenda
| 9:00 AM CT | Welcome |
|---|---|
| 9:15 AM CT | Preventing Limb Loss in Patients with PAD: Updated Guidelines Demetria M. (McNeal) Bolden, PhD, MBA, CPTD |
| 10:00 AM CT | Break |
| 10:10 AM CT | Obstructive Sleep Apnea: Implications for Cardiovascular Health Lisa L.M. Maher, DNP, ARNP, FNP-BC, FPCNA |
| 10:55 PM CT | Adjourn |
Topics
Obstructive Sleep Apnea: Implications for Cardiovascular Health
- Discuss the clinical impact of untreated Obstructive Sleep Apnea on cardiovascular and metabolic health.
- Describe current trends in diagnosis, including at-home sleep studies and wearable technologies.
- Review traditional and emerging therapies to treat Obstructive Sleep Apnea with an emphasis on the impact of healthcare disparities in access to care and strategies for earlier identification and for improving equity in Obstructive Sleep Apnea and management.
Preventing Limb Loss in Patients with PAD: Updated Guidelines
- Examine profound and disparate risks for poor cardiovascular outcomes and loss of limb associated with un and undertreated PAD across patient populations experiencing social determinants of health.
- Discuss PAD-associated major adverse CV event risk factors starting with atherosclerosis, elevated LDL-C, elevated Lp(a), thrombosis, hypertension, and diabetes.
- Explore risk reduction guideline-directed therapies to improve cardiovascular outcomes for patients with PAD
Thank you for the independent education grant support of this program from Eli Lilly and Company and Novartis Pharmaceuticals.